Skip to main content

BENZYLPENICILLIN DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)

Product name
BENZYLPENICILLIN DEMOGEN
Date registered
Evaluation commenced
Decision date
Approval time
122 (255 working days)
Active ingredients
benzylpenicillin sodium
Registration type
New generic medicine
Indication

For the treatment of infections caused by benzylpenicillin sensitive organisms. These include Streptococcus pyogenes and most other Gram-positive organisms. It is also indicated for the treatment of syphilis. BENZYLPENICILLIN DEMOGEN may also be used for the prevention of bacterial endocarditis in dental and upper respiratory tract procedures and prevention of wound infections and sepsis in surgical procedures where Streptococci are the likely pathogens.